International Patent: DOUBLE-MUTANT INACTIVATED TELOMERASE, VECTOR COMPRISING SAME, AND USE THEREOF

GENEVA, July 9 -- SHANGHAI JUVENSIS THERAPEUTICS BIOMEDICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/070729) for “DOUBLE-MUTANT INACTIVATED TELOMERASE, VECTOR COMPRISING SAME, AND USE THEREOF”. With publication no. WO/2026/145805, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 9/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....